JP2006500321A - α−ラクトアルブミン（ＨＡＭＬＥＴ）および補因子の活性複合体 - Google Patents

α−ラクトアルブミン（ＨＡＭＬＥＴ）および補因子の活性複合体 Download PDF

Info

Publication number
JP2006500321A
JP2006500321A JP2004503504A JP2004503504A JP2006500321A JP 2006500321 A JP2006500321 A JP 2006500321A JP 2004503504 A JP2004503504 A JP 2004503504A JP 2004503504 A JP2004503504 A JP 2004503504A JP 2006500321 A JP2006500321 A JP 2006500321A
Authority
JP
Japan
Prior art keywords
lactalbumin
biologically active
variant
hamlet
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004503504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500321A5 (https=
Inventor
カタリナ・スヴァンボルイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2006500321A publication Critical patent/JP2006500321A/ja
Publication of JP2006500321A5 publication Critical patent/JP2006500321A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
JP2004503504A 2002-05-08 2003-05-08 α−ラクトアルブミン（ＨＡＭＬＥＴ）および補因子の活性複合体 Pending JP2006500321A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210464.4A GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment
PCT/IB2003/002366 WO2003095490A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor

Publications (2)

Publication Number Publication Date
JP2006500321A true JP2006500321A (ja) 2006-01-05
JP2006500321A5 JP2006500321A5 (https=) 2006-06-22

Family

ID=9936230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004503504A Pending JP2006500321A (ja) 2002-05-08 2003-05-08 α−ラクトアルブミン（ＨＡＭＬＥＴ）および補因子の活性複合体

Country Status (8)

Country Link
US (2) US7270822B2 (https=)
EP (1) EP1506233B8 (https=)
JP (1) JP2006500321A (https=)
AU (1) AU2003233116B2 (https=)
CA (1) CA2485223A1 (https=)
DK (1) DK1506233T3 (https=)
GB (1) GB0210464D0 (https=)
WO (1) WO2003095490A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
JP2007524708A (ja) * 2004-02-26 2007-08-30 ハムレット・ファルマ・アーベー 血管新生を阻害するラクトアルブミン
GB0408752D0 (en) * 2004-04-20 2004-05-26 Hamlet Ltd Therapeutic treatment
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
WO2009135494A2 (en) * 2008-05-09 2009-11-12 Nya Hamlet Pharma Ab Alpha-lactalbumin composition for the treatment of actinic keratosis
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JP2961625B2 (ja) 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
AU7792294A (en) 1994-08-16 1996-03-07 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5614191A (en) * 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
DK1032596T3 (da) 1997-11-21 2007-09-10 Nya Hamlet Pharma Ab Fremgangsmåde til fremstilling af lactalbumin
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
EP1311288A1 (en) 2000-01-20 2003-05-21 Ottawa Health Research Institute Immunostimulatory nucleic acids for inducing a th2 immune response
EP1268534A2 (en) 2000-03-24 2003-01-02 Filgen Biosciences, Inc. Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
EP2206720A1 (en) 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
GB0205347D0 (en) * 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
JP2007524708A (ja) * 2004-02-26 2007-08-30 ハムレット・ファルマ・アーベー 血管新生を阻害するラクトアルブミン

Also Published As

Publication number Publication date
EP1506233B1 (en) 2014-04-02
CA2485223A1 (en) 2003-11-20
DK1506233T3 (da) 2014-07-07
US20060074017A1 (en) 2006-04-06
EP1506233A1 (en) 2005-02-16
US7270822B2 (en) 2007-09-18
GB0210464D0 (en) 2002-06-12
AU2003233116B2 (en) 2009-03-26
WO2003095490A1 (en) 2003-11-20
AU2003233116A1 (en) 2003-11-11
US20080167233A1 (en) 2008-07-10
US7713533B2 (en) 2010-05-11
EP1506233B8 (en) 2014-09-24

Similar Documents

Publication Publication Date Title
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
TWI327068B (en) L-methionine as a stabilizer for nesp/epo in hsa-free formulations
ES3057136T3 (en) Compositions comprising peptide wkdeagkplvk
US12331073B2 (en) Preparation of biologically active complexes
AU2019339260B2 (en) Modified peptide fragments of Cav-1 protein and the use thereof in the treatment of fibrosis
JP2010510180A (ja) α−ラクトアルブミン組成物
KR102567756B1 (ko) 커큐민-펩타이드 컨쥬게이트 및 이의 제형
JP5685773B2 (ja) 血管新生および創傷治癒活性がある薬剤
JP2025169367A (ja) 筋萎縮を治療するためのペプチド
JP2023539476A (ja) アネキシンａ１のｎ末端ペプチド製剤及び方法
US20250277010A1 (en) Agent for treatment of dermatological disorders
CN100509055C (zh) 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡
JP3544180B2 (ja) 安定化した顆粒球コロニー刺激因子
TW202140074A (zh) Fgf-21結合物調配物
US20110224152A1 (en) Synthetic arginine substituted peptides and their use
JP2005530703A (ja) 生物学的に活性な複合体
JP2007524708A (ja) 血管新生を阻害するラクトアルブミン
WO1998040096A1 (en) Preventives and/or remedies for multiple organ failure
TWI863205B (zh) 具傷口癒合功效之鱸魚胜肽及其組成物
JP3815726B2 (ja) 緩衝液からなるローヤルゼリーの鮮度保持剤
JP2024539643A (ja) コラーゲン７タンパク質補充療法
JP2024532407A (ja) ラクトフェリン組成物及び使用方法
JPH0881387A (ja) 創傷治癒剤
BR112021007687A2 (pt) engenharia de enzimas degradantes de cistina/cisteína primatas para usos terapêuticos
HK40072504A (en) Agent for use in treatment or prevention of ophthalmic disorders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060502

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070403

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090721

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091222